- Home
- JG vs TPST Comparison
JG vs TPST Comparison
Compare JG & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JG
- TPST
- Stock Information
- Founded
- JG 2012
- TPST 2011
- Country
- JG China
- TPST United States
- Employees
- JG N/A
- TPST N/A
- Industry
- JG Computer Software: Programming Data Processing
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- JG Technology
- TPST Health Care
- Exchange
- JG Nasdaq
- TPST Nasdaq
- Market Cap
- JG 46.7M
- TPST 40.4M
- IPO Year
- JG 2018
- TPST N/A
- Fundamental
- Price
- JG $11.80
- TPST $0.86
- Analyst Decision
- JG Strong Buy
- TPST Strong Buy
- Analyst Count
- JG 1
- TPST 3
- Target Price
- JG $7.00
- TPST $21.67
- AVG Volume (30 Days)
- JG 2.4M
- TPST 877.6K
- Earning Date
- JG 03-11-2025
- TPST 03-18-2025
- Dividend Yield
- JG N/A
- TPST N/A
- EPS Growth
- JG N/A
- TPST N/A
- EPS
- JG N/A
- TPST N/A
- Revenue
- JG $42,829,425.00
- TPST N/A
- Revenue This Year
- JG $77.44
- TPST N/A
- Revenue Next Year
- JG N/A
- TPST N/A
- P/E Ratio
- JG N/A
- TPST N/A
- Revenue Growth
- JG 0.23
- TPST N/A
- 52 Week Low
- JG $2.36
- TPST $0.70
- 52 Week High
- JG $20.94
- TPST $6.00
- Technical
- Relative Strength Index (RSI)
- JG 57.83
- TPST 40.89
- Support Level
- JG $10.76
- TPST $0.85
- Resistance Level
- JG $13.26
- TPST $0.95
- Average True Range (ATR)
- JG 2.02
- TPST 0.05
- MACD
- JG -0.05
- TPST -0.00
- Stochastic Oscillator
- JG 42.87
- TPST 9.45
About JG Aurora Mobile Limited
Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, they gain access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.